{"title":"生姜能改善心血管健康指标吗?grade评估的系统评价和计划的随机对照试验剂量-反应荟萃分析方案。","authors":"Ali Jafari, Amirhossein Sahebkar","doi":"10.1186/s13643-025-02867-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs), which encompass a range of disorders impacting the heart and blood vessels, continue to pose a significant global public health challenge. Ginger (Zingiber officinale) has attracted attention among various treatment options for its potential advantages in promoting cardiovascular well-being. Renowned for its anti-inflammatory, antioxidant, and anti-hypertensive properties, ginger is a widely used culinary and medicinal plant. The objective of this research is to provide a comprehensive summary and systematic analysis of the existing scientific literature pertaining to the effects of ginger supplementation on glycemic profile, lipid profile, anthropometric measures, blood pressure, inflammatory markers, liver function tests, oxidative stress parameters, and adipokines. This analysis aims to establish a foundation for clinical interventions.</p><p><strong>Methods: </strong>A methodical electronic exploration will be carried out to discover articles in various databases such as Scopus, PubMed, EMBASE, CENTRAL, and Web of Science. The search will specifically target randomized controlled trials (RCTs) that include both healthy and diseased individuals. Two evaluators will independently review articles, extract information, and evaluate the quality of the studies using the Cochrane risk of bias assessment tool (RoB 2). Any discrepancies will be addressed by involving a third reviewer. The quality of cumulative evidence will be evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria. Should a sufficient quantity of suitable studies be found, a meta-analysis will be conducted on the chosen outcomes.</p><p><strong>Discussion: </strong>This protocol outlines a comprehensive approach for systematically reviewing and conducting a dose-response meta-analysis on the effects of ginger supplementation on CVD risk factors. The proposed methodological rigor, including independent evaluation and GRADE assessment, will ensure high-quality evidence synthesis from available RCTs. The findings from this planned review will help inform future research directions and potentially guide clinical recommendations regarding ginger supplementation for cardiovascular health.</p><p><strong>Systematic review registration: </strong>PROSPERO: CRD42024571362.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":"14 1","pages":"121"},"PeriodicalIF":6.3000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131349/pdf/","citationCount":"0","resultStr":"{\"title\":\"Can ginger improve cardiovascular health indices? A protocol for a GRADE-assessed systematic review and planned dose-response meta-analysis of randomized controlled trials.\",\"authors\":\"Ali Jafari, Amirhossein Sahebkar\",\"doi\":\"10.1186/s13643-025-02867-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cardiovascular diseases (CVDs), which encompass a range of disorders impacting the heart and blood vessels, continue to pose a significant global public health challenge. Ginger (Zingiber officinale) has attracted attention among various treatment options for its potential advantages in promoting cardiovascular well-being. Renowned for its anti-inflammatory, antioxidant, and anti-hypertensive properties, ginger is a widely used culinary and medicinal plant. The objective of this research is to provide a comprehensive summary and systematic analysis of the existing scientific literature pertaining to the effects of ginger supplementation on glycemic profile, lipid profile, anthropometric measures, blood pressure, inflammatory markers, liver function tests, oxidative stress parameters, and adipokines. This analysis aims to establish a foundation for clinical interventions.</p><p><strong>Methods: </strong>A methodical electronic exploration will be carried out to discover articles in various databases such as Scopus, PubMed, EMBASE, CENTRAL, and Web of Science. The search will specifically target randomized controlled trials (RCTs) that include both healthy and diseased individuals. Two evaluators will independently review articles, extract information, and evaluate the quality of the studies using the Cochrane risk of bias assessment tool (RoB 2). Any discrepancies will be addressed by involving a third reviewer. The quality of cumulative evidence will be evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria. Should a sufficient quantity of suitable studies be found, a meta-analysis will be conducted on the chosen outcomes.</p><p><strong>Discussion: </strong>This protocol outlines a comprehensive approach for systematically reviewing and conducting a dose-response meta-analysis on the effects of ginger supplementation on CVD risk factors. The proposed methodological rigor, including independent evaluation and GRADE assessment, will ensure high-quality evidence synthesis from available RCTs. The findings from this planned review will help inform future research directions and potentially guide clinical recommendations regarding ginger supplementation for cardiovascular health.</p><p><strong>Systematic review registration: </strong>PROSPERO: CRD42024571362.</p>\",\"PeriodicalId\":22162,\"journal\":{\"name\":\"Systematic Reviews\",\"volume\":\"14 1\",\"pages\":\"121\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2025-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131349/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Systematic Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13643-025-02867-3\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Systematic Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13643-025-02867-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:心血管疾病(cvd)包括一系列影响心脏和血管的疾病,继续对全球公共卫生构成重大挑战。生姜(Zingiber officinale)因其促进心血管健康的潜在优势而在各种治疗方案中引起了人们的注意。生姜因其抗炎、抗氧化和抗高血压的特性而闻名,是一种广泛使用的烹饪和药用植物。本研究的目的是对现有的有关补充生姜对血糖、血脂、人体测量、血压、炎症标志物、肝功能测试、氧化应激参数和脂肪因子的影响的科学文献进行全面总结和系统分析。本分析旨在为临床干预奠定基础。方法:在Scopus、PubMed、EMBASE、CENTRAL和Web of Science等数据库中进行系统的电子检索。搜索将特别针对随机对照试验(rct),包括健康和患病个体。两名评估员将独立审查文章,提取信息,并使用Cochrane偏倚风险评估工具(RoB 2)评估研究的质量。任何差异将由第三方审稿人处理。累积证据的质量将使用分级推荐、评估、发展和评估(GRADE)标准进行评估。如果找到足够数量的合适研究,将对选择的结果进行荟萃分析。讨论:本方案概述了一种全面的方法,系统地回顾和开展生姜补充对心血管疾病危险因素影响的剂量反应荟萃分析。建议的方法严谨性,包括独立评估和GRADE评估,将确保从现有随机对照试验中获得高质量的证据合成。这项计划审查的结果将有助于为未来的研究方向提供信息,并可能指导有关补充生姜促进心血管健康的临床建议。系统评价注册:PROSPERO: CRD42024571362。
Can ginger improve cardiovascular health indices? A protocol for a GRADE-assessed systematic review and planned dose-response meta-analysis of randomized controlled trials.
Background: Cardiovascular diseases (CVDs), which encompass a range of disorders impacting the heart and blood vessels, continue to pose a significant global public health challenge. Ginger (Zingiber officinale) has attracted attention among various treatment options for its potential advantages in promoting cardiovascular well-being. Renowned for its anti-inflammatory, antioxidant, and anti-hypertensive properties, ginger is a widely used culinary and medicinal plant. The objective of this research is to provide a comprehensive summary and systematic analysis of the existing scientific literature pertaining to the effects of ginger supplementation on glycemic profile, lipid profile, anthropometric measures, blood pressure, inflammatory markers, liver function tests, oxidative stress parameters, and adipokines. This analysis aims to establish a foundation for clinical interventions.
Methods: A methodical electronic exploration will be carried out to discover articles in various databases such as Scopus, PubMed, EMBASE, CENTRAL, and Web of Science. The search will specifically target randomized controlled trials (RCTs) that include both healthy and diseased individuals. Two evaluators will independently review articles, extract information, and evaluate the quality of the studies using the Cochrane risk of bias assessment tool (RoB 2). Any discrepancies will be addressed by involving a third reviewer. The quality of cumulative evidence will be evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria. Should a sufficient quantity of suitable studies be found, a meta-analysis will be conducted on the chosen outcomes.
Discussion: This protocol outlines a comprehensive approach for systematically reviewing and conducting a dose-response meta-analysis on the effects of ginger supplementation on CVD risk factors. The proposed methodological rigor, including independent evaluation and GRADE assessment, will ensure high-quality evidence synthesis from available RCTs. The findings from this planned review will help inform future research directions and potentially guide clinical recommendations regarding ginger supplementation for cardiovascular health.
期刊介绍:
Systematic Reviews encompasses all aspects of the design, conduct and reporting of systematic reviews. The journal publishes high quality systematic review products including systematic review protocols, systematic reviews related to a very broad definition of health, rapid reviews, updates of already completed systematic reviews, and methods research related to the science of systematic reviews, such as decision modelling. At this time Systematic Reviews does not accept reviews of in vitro studies. The journal also aims to ensure that the results of all well-conducted systematic reviews are published, regardless of their outcome.